| As the race for a vaccine against the coronavirus heats up, the US faces another potential crisis: a shortage of syringes. A potential vaccine could receive emergency approval as early as winter 2020. But industry leaders and experts are warning the US has only a short window of time to scale up syringe supplies in order to deal with the vast number of inoculations required to control the pandemic. The biggest danger for shortage will not come in the first wave of any potential vaccination program, but in the second and third waves in 2021. Then, manufacturers will need to roughly double capacity to meet demand in the US alone. |
Connect - Convene - Collaborate